Aegis Maintains Ironwood Pharma (IRWD) at Buy; Still Positive on LINZESS Amid Slower Start
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.46 -0.11 (3.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.57 | 52 Week High | $16.89 | |||
| Open | $3.52 | 52 Week Low | $7.35 | |||
| Day High | $3.54 | P/E | N/A | |||
| Day Low | $3.38 | EPS | $-2.35 | |||
| Volume | 1,261,158 | |||||
